Drawing for HENIK

USPTO serial 88425574

HENIK

Reviewed by CopyMark Law Group

Reg. 6674770Status 700Registered
Filing date
Status date
Registration date
Mar 22, 2022
Examiner
PIERCE, ALEXANDRA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HENIK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Peter S. Sloane

Peter S. Sloane Leason Ellis LLPOne North Lexington Ave., Suite 1200White Plains, NY 10601United States

Goods and services

ClassDescriptionStatusFirst use
005Medicated bath salts; medicated liquid soaps; disinfectant and anti-bacterial liquid soaps; medicated skin care preparations; Hemp related products, namely, medicinal oils and salves; concentrated medicated pastes for the teeth and gums, for the hair and scalp, and for use on skin rashes; tinctures, tablets and capsules for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; medicated oils, salves, and concentrated pastes for the treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders, and anxiety; tinctures, tablets and capsules each containing resins and oils derived from hemp for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of hemp, namely, resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicated topical skin creams, medicated bar and liquid soaps; medicated bath additives, namely, bath herbs, bath oils, bath salts; medicated body creams, medicated body oils, medicated face and body lotions, medicated face and body milk, medicated face lotion, and medicated skin care preparations each of the foregoing containing derivatives of hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid; personal sexual lubricants; transdermal patches containing derivatives of hemp for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; hemp derivatives for medicinal use; hemp related products, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils derived from hemp for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; all of the foregoing solely derived from cannabis with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBDACTIVE—
029Oils derived from hemp for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; hemp related products, namely, oils for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; food products containing hemp, resins, and oils, namely, butter; fruit based energy food bars; seed and nut-based energy food bars; processed edible hemp seeds; all of the foregoing solely derived from hemp with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBDACTIVE—
031Live hemp plants; hemp seeds for planting and agricultural use; all of the foregoing solely derived from hemp with a delta-9 THC concentration of not more than 0.3% dry weight basisACTIVE—
034Smokers' articles, namely, grinders for use with hemp, dried hemp for smoking; derivatives of hemp, namely, processed resins and oils in the nature of flavorings in liquid form, other than essential oils for use in electronic cigarettes and oral smokeless vaporizers; e-liquids comprised of hemp derivatives being flavorings in liquid form, other than essential oils for use in electronic cigarettes and oral smokeless vaporizers for recreational use; smokers' articles, namely, smoking pipes, oral vaporizers for smokers; smokers' articles, namely, pouches for use with hemp, lighters for smokers; all of the foregoing solely derived from hemp with a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBD or exclusively for use with goods solely derived from hemp having a delta-9 THC concentration of not more than 0.3% dry weight basis and not containing CBDACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 27, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 27, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 27, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 27, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 27, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 22, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 4, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 4, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 15, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 30, 2021PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 23, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 23, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Nov 23, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 23, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 23, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 17, 2021ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Oct 25, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 25, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 25, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 25, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 25, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 21, 2021PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Sep 8, 2021FIXDELECTRONIC RECORD REVIEW COMPLETE—
Sep 3, 2021ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Aug 30, 2021FIXDELECTRONIC RECORD REVIEW COMPLETE—
Aug 27, 2021ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Aug 22, 2021EXPTEXPARTE APPEAL TERMINATED—
Aug 20, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 20, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Aug 20, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 20, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 20, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 15, 2021DOCKASSIGNED TO EXAMINER—
Apr 16, 2021DOCKASSIGNED TO EXAMINER—
Apr 1, 2021JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Jan 14, 2021GEA1NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED—
Jan 14, 2021GECDACTION DENYING REQ FOR RECON E-MAILED—
Jan 14, 2021CNCFACTION CONTINUING FINAL - COMPLETED—
Dec 2, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 2, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 23, 2020ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 23, 2020EXPIEX PARTE APPEAL-INSTITUTED—
Nov 23, 2020JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Nov 23, 2020EXAFEXPARTE APPEAL RECEIVED AT TTAB—
May 21, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 21, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 21, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 22, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 22, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 22, 2020ALIEASSIGNED TO LIE—
Apr 17, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 17, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 17, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 17, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 15, 2019DOCKASSIGNED TO EXAMINER—
May 30, 2019DOCKASSIGNED TO EXAMINER—
May 28, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 14, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance